Correlation Between HANSOH PHARMAC and ASPEN PHARUNADR

Can any of the company-specific risk be diversified away by investing in both HANSOH PHARMAC and ASPEN PHARUNADR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HANSOH PHARMAC and ASPEN PHARUNADR into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HANSOH PHARMAC HD 00001 and ASPEN PHARUNADR 1, you can compare the effects of market volatilities on HANSOH PHARMAC and ASPEN PHARUNADR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HANSOH PHARMAC with a short position of ASPEN PHARUNADR. Check out your portfolio center. Please also check ongoing floating volatility patterns of HANSOH PHARMAC and ASPEN PHARUNADR.

Diversification Opportunities for HANSOH PHARMAC and ASPEN PHARUNADR

0.4

Correlation Coefficient

HANSOH PHARMAC  ASPEN PHARUNADR

Very weak diversification

The 3 months correlation between HANSOH and ASPEN is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding HANSOH PHARMAC HD 00001 and ASPEN PHARUNADR 1 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ASPEN PHARUNADR 1 and HANSOH PHARMAC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HANSOH PHARMAC HD 00001 are associated (or correlated) with ASPEN PHARUNADR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ASPEN PHARUNADR 1 has no effect on the direction of HANSOH PHARMAC i.e., HANSOH PHARMAC and ASPEN PHARUNADR go up and down completely randomly.

Pair Corralation between HANSOH PHARMAC and ASPEN PHARUNADR

Assuming the 90 days horizon HANSOH PHARMAC HD 00001 is expected to under-perform the ASPEN PHARUNADR. In addition to that, HANSOH PHARMAC is 1.97 times more volatile than ASPEN PHARUNADR 1. It trades about -0.15 of its total potential returns per unit of risk. ASPEN PHARUNADR 1 is currently generating about -0.08 per unit of volatility. If you would invest  880.00  in ASPEN PHARUNADR 1 on October 12, 2024 and sell it today you would lose (30.00) from holding ASPEN PHARUNADR 1 or give up 3.41% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	94.44%
Values	Daily Returns

HANSOH PHARMAC HD 00001  vs.  ASPEN PHARUNADR 1

HANSOH PHARMAC HD

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days HANSOH PHARMAC HD 00001 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

ASPEN PHARUNADR 1

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ASPEN PHARUNADR 1 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with HANSOH PHARMAC and ASPEN PHARUNADR

The main advantage of trading using opposite HANSOH PHARMAC and ASPEN PHARUNADR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HANSOH PHARMAC position performs unexpectedly, ASPEN PHARUNADR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ASPEN PHARUNADR will offset losses from the drop in ASPEN PHARUNADR's long position.

The idea behind HANSOH PHARMAC HD 00001 and ASPEN PHARUNADR 1 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.